Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling - PubMed (original) (raw)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L Gavin et al. Science. 2006.
Abstract
Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.
Figures
Figure 1
T dependent antibody responses of Myd88−/−; TrifLps2/Lps2 and control mice using CFA. Two month old mice were immunized with TNP-Hy in CFA on day 0 and boosted with antigen in PBS on day 21. Each point represents the serum anti-TNP titer of an individual mouse. IgE titers represent ng/ml, whereas other measurements represent reciprocal serum dilution yielding half maximal signal. Closed circles, wild type C57BL/6; open squares, Myd88−/−; TrifLps2/Lps2 double knockout mice. Statistically significant differences between mutant and control groups are as indicated with asterisks; *, p>.05; **, p>.01. For methods, see (9).
Figure 2
Comparison of serum antibody responses of C57BL/6 and Myd88−/−; TrifLps2/Lps2 mice given immunogen in different adjuvants. Groups of four mice were immunized with 100μg TNP-KLH in PBS in the indicated adjuvants and anti-TNP titers of the indicated immunoglobulin isotypes determined on day 7 and 14.
Figure 3
Preimmune serum immunoglobulin levels in Myd88−/−; TrifLps2/Lps2 compared to wild type C57BL/6 controls as measured by ELISA. Each point represents data from a different mouse. Closed circles, wild type, C57BL/6; open squares, Myd88−/−; TrifLps2/Lps2 mice.
Comment in
- Immunology. Mouse studies question importance of toll-like receptors to vaccines.
Wickelgren I. Wickelgren I. Science. 2006 Dec 22;314(5807):1859-60. doi: 10.1126/science.314.5807.1859a. Science. 2006. PMID: 17185572 No abstract available.
Similar articles
- Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
Leenaars PP, Hendriksen CF, Angulo AF, Koedam MA, Claassen E. Leenaars PP, et al. Vet Immunol Immunopathol. 1994 Mar;40(3):225-41. doi: 10.1016/0165-2427(94)90022-1. Vet Immunol Immunopathol. 1994. PMID: 8160361 - Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
Chaitra MG, Nayak R, Shaila MS. Chaitra MG, et al. Vaccine. 2007 Oct 10;25(41):7168-76. doi: 10.1016/j.vaccine.2007.07.026. Epub 2007 Aug 2. Vaccine. 2007. PMID: 17709160 - The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. Mata-Haro V, et al. Science. 2007 Jun 15;316(5831):1628-32. doi: 10.1126/science.1138963. Science. 2007. PMID: 17569868 - Toll or toll-free adjuvant path toward the optimal vaccine development.
Ishii KJ, Akira S. Ishii KJ, et al. J Clin Immunol. 2007 Jul;27(4):363-71. doi: 10.1007/s10875-007-9087-x. Epub 2007 Mar 17. J Clin Immunol. 2007. PMID: 17370119 Review. - Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.
Prchal M, Pilz A, Simma O, Lingnau K, von Gabain A, Strobl B, Müller M, Decker T. Prchal M, et al. Vaccine. 2009 Dec 30;27 Suppl 6:G17-20. doi: 10.1016/j.vaccine.2009.10.016. Vaccine. 2009. PMID: 20006134 Review.
Cited by
- Co-formulation of the rF1V plague vaccine with depot-formulated cytokines enhances immunogenicity and efficacy to elicit protective responses against aerosol challenge in mice.
Galloway DR, Li J, Nguyen NX, Falkenberg FW, Henning L, Krile R, Chou YL, Herron JN, Hale JS, Williamson ED. Galloway DR, et al. Front Immunol. 2024 Mar 28;15:1277526. doi: 10.3389/fimmu.2024.1277526. eCollection 2024. Front Immunol. 2024. PMID: 38605961 Free PMC article. - Control of adaptive immunity by pattern recognition receptors.
Carroll SL, Pasare C, Barton GM. Carroll SL, et al. Immunity. 2024 Apr 9;57(4):632-648. doi: 10.1016/j.immuni.2024.03.014. Immunity. 2024. PMID: 38599163 Review. - Review: Unravelling the Role of DNA Sensing in Alum Adjuvant Activity.
Gatt Z, Gunes U, Raponi A, da Rosa LC, Brewer JM. Gatt Z, et al. Discov Immunol. 2022 Dec 29;2(1):kyac012. doi: 10.1093/discim/kyac012. eCollection 2023. Discov Immunol. 2022. PMID: 38567066 Free PMC article. Review. - Effect of Mycolic Acids on Host Immunity and Lipid Metabolism.
Wang H, Liu D, Zhou X. Wang H, et al. Int J Mol Sci. 2023 Dec 28;25(1):396. doi: 10.3390/ijms25010396. Int J Mol Sci. 2023. PMID: 38203570 Free PMC article. Review. - Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation.
Desai DN, Mahal A, Varshney R, Obaidullah AJ, Gupta B, Mohanty P, Pattnaik P, Mohapatra NC, Mishra S, Kandi V, Rabaan AA, Mohapatra RK. Desai DN, et al. ACS Omega. 2023 Jul 24;8(31):27953-27968. doi: 10.1021/acsomega.3c02030. eCollection 2023 Aug 8. ACS Omega. 2023. PMID: 37576639 Free PMC article. Review.
References
- Takeda K, Akira S. Int Immunol. 2005;17:1. - PubMed
- Beutler B, et al. Annu Rev Immunol. 2006;24:353. - PubMed
- Andersson J, Sjoberg O, Moller G. Transplant Rev. 1972;11:131. - PubMed
- Pasare C, Medzhitov R. Nature. 2005;438:364. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases